Detection rate of unknown primary tumour by using somatostatin receptor PET/CT in patients with metastatic neuroendocrine tumours: a meta-analysis
ConclusionsSomatostatin receptor PET/CT is very useful in detecting CUP-NETs in patients with metastatic disease. More studies on the change of management by using this imaging method in this setting are needed.
Source: Endocrine - Category: Endocrinology Source Type: research
More News: Brain | Computers | CT Scan | Databases & Libraries | Endocrinology | Neurology | Pancreas | PET Scan | Study